Evidence mapPaperPMID 38612641Full record

ArticleInternational journal of molecular sciences2024

Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer's Disease.

Lynn Pulliam, Bing Sun, Erin McCafferty, Steven A Soper, Malgorzata A Witek, Mengjia Hu, Judith M Ford, Sarah Song, Dimitrios Kapogiannis, Marshall J Glesby and 15 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 17 institutions in 1 country.

Lynn PulliamDepartment of Laboratory Medicine, University of California, San Francisco, CA 94143, USA.
Bing SunDepartment of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.
Erin McCaffertyDepartment of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.
Steven A SoperDepartment of Chemistry, The University of Kansas, Lawrence, KS 66045, USA.
Malgorzata A WitekDepartment of Chemistry, The University of Kansas, Lawrence, KS 66045, USA.
Mengjia HuCancer Biology, The University of Kansas Medical Center, Kansas City, KS 66103, USA.
Judith M FordDepartment of Mental Health, San Francisco VA Health Care System, San Francisco, CA 94121, USA.
Sarah SongDepartment of Mental Health, San Francisco VA Health Care System, San Francisco, CA 94121, USA.
Dimitrios KapogiannisLaboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 20892, USA.ORCID 0000-0003-2181-3118
Marshall J GlesbyDepartment of Medicine, Weill Cornell Medical College, New York City, NY 10021, USA.ORCID 0000-0002-2145-148X
Daniel MerensteinDepartment of Family Medicine, Georgetown University School of Medicine, Washington, DC 20007, USA.
Phyllis C TienDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Heather FreasierDepartment of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Audrey FrenchDepartment of Medicine, Cook County Health, Chicago, IL 60612, USA.
Heather McKayDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Monica M DiazDepartment of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.ORCID 0000-0001-9663-5948
Igho OfotokunDepartment of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jordan E LakeDepartment of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Joseph B MargolickDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Eun-Young KimDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.ORCID 0000-0002-7436-7396
Steven R LevineDepartment of Neurology, State University of New York College of Medicine and Downstate Medical Sciences University, Brooklyn, NY 11203, USA.
Margaret A FischlDepartment of Medicine, University of Miami, Miami, FL 33136, USA.
Wei LiDepartment of Clinical and Diagnostic Sciences, University of Alabama, Birmingham, AL 35294, USA.
Jeremy MartinsonDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Norina TangDepartment of Laboratory Medicine, San Francisco VA Health Care System, San Francisco, CA 94121, USA.ORCID 0009-0002-3485-1762
San Francisco VA Health Care System · USUniversity of California, San Francisco · USJohns Hopkins University · USUniversity of Kansas · USCook County Health and Hospitals System · USCornell University · USEmory University · USGeorgetown University · USNational Institutes of Health · USNorthwestern University · USState University of New York · USThe University of Kansas Cancer Center · USThe University of Texas Health Science Center at Houston · USUniversity of Alabama at Birmingham · USUniversity of Miami · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

UAB Center for AIDS Research (CFAR)P30AI027767 · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 1988 to 2025
$12.1M
SWG: EHEP30AI036214 · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 1994 to 2025
$11.2M
Infant Immunization to Reduce Pneumonia in HIV +ve womenP30AI050409 · EMORY UNIVERSITY · 2002 to 2025
$11.1M
UNC Center for AIDS Research Core F BiostatisticsP30AI050410 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2001 to 2025
$10.9M
UCLA Clinical and Translational Science InstituteUL1TR001881 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$9.9M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · 2022 to 2025
$6.0M
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort StudyU01HL146193 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$4.8M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2025 to 2025
$4.4M
Los Angeles CRS for the MACS/WIHS Combined Cohort StudyU01HL146333 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$4.3M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)U01HL146204 · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2025 to 2025
$4.1M
University of Pittsburgh MACS/WIHS CCSU01HL146208 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$4.0M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC CenterU01HL146201 · JOHNS HOPKINS UNIVERSITY · 2025 to 2025
$4.0M
CSRD VA I01 CX002322CSRD VA IK6 CX002519NCATS NIH HHS KL2 TR001432NCATS NIH HHS TL1 TR001431NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01 HL146201NHLBI NIH HHS U01 HL146202NHLBI NIH HHS U01 HL146203NHLBI NIH HHS U01 HL146204NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01 HL146208NHLBI NIH HHS U01 HL146240NHLBI NIH HHS U01 HL146241NHLBI NIH HHS U01 HL146242NHLBI NIH HHS U01 HL146245NHLBI NIH HHS U01 HL146333NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI036214NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIBIB NIH HHS P41 EB020594NIGMS NIH HHS P20 GM130423NIMH NIH HHS P30 MH116867NIMH NIH HHS R01 MH121121
6 · The paper itself

Abstract

Long COVID (LongC) is associated with a myriad of symptoms including cognitive impairment. We reported at the beginning of the COVID-19 pandemic that neuronal-enriched or L1CAM+ extracellular vesicles (nEVs) from people with LongC contained proteins associated with Alzheimer's disease (AD). Since that time, a subset of people with prior COVID infection continue to report neurological problems more than three months after infection. Blood markers to better characterize LongC are elusive. To further identify neuronal proteins associated with LongC, we maximized the number of nEVs isolated from plasma by developing a hybrid EV Microfluidic Affinity Purification (EV-MAP) technique. We isolated nEVs from people with LongC and neurological complaints, AD, and HIV infection with mild cognitive impairment. Using the OLINK platform that assesses 384 neurological proteins, we identified 11 significant proteins increased in LongC and 2 decreased (BST1, GGT1). Fourteen proteins were increased in AD and forty proteins associated with HIV cognitive impairment were elevated with one decreased (IVD). One common protein (BST1) was decreased in LongC and increased in HIV. Six proteins (MIF, ENO1, MESD, NUDT5, TNFSF14 and FYB1) were expressed in both LongC and AD and no proteins were common to HIV and AD. This study begins to identify differences and similarities in the neuronal response to LongC versus AD and HIV infection.

Indexed as

Alzheimer DiseaseCOVID-19Extracellular VesiclesHIV InfectionsHumansMicrofluidicsPandemicsPost-Acute COVID-19 SyndromeAlzheimer’s diseaseextracellular vesiclesHIVL1CAMlong COVIDmicrofluidicsOLINK

Identifiers

PMID38612641
PMCPMC11011771
OpenAlexW4393356639

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.